Nucleoside analogs in the treatment of chronic viral hepatitis. Efficiency and complications.
Zoulim
F
F
Liver Unit, Hôtel Dieu, Lyon, France.
Trépo
C
C
D000212:Acyclovir / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use; D002908:Chronic Disease; D006525:Hepatitis, Viral, Human / Q000188:drug therapy*; D006801:Humans; D009705:Nucleosides / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*; D012254:Ribavirin / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use; D014740:Vidarabine / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use
D009705:Nucleosides; D012254:Ribavirin; D014740:Vidarabine; D000212:Acyclovir